Leading Italian pharmaceutical companies 2021, by revenue
In 2021, Pfizer S.r.l. was the leading Italian pharmaceutical company, with an annual revenue of approximately 1.8 billion euros. Chiesi and Sanofi came second and third in the ranking, both with revenue of 1.4 billion euros. According to the the data provided by Competitive Data, closing the ranking of the five largest Italian pharmaceutical firms was Janssen Cilag with a revenue of 1.1billion euros.
Italian pharmaceutical industry
In 2022, Italy accounted for 2.4 percent of the global pharmaceutical sales, ranking sixth among the top ten pharmaceutical markets worldwide. The production value of the Italian pharmaceutical industry grew steadily over time, peaking in 2023 at 52 billion euros.
Pharmaceutical trade
The share of Italian pharmaceutical products exported abroad grew remarkably. During the twenty-year period from 1997 to 2019, the percentage of production exported grew from 34 to 96 percent. In 2021, Belgium and the United States were the leading destination countries for the Italian pharmaceutical preparations.
